Miricorilant 150 mg
CORT118335-861
Phase 1 small_molecule completed
Quick answer
Miricorilant 150 mg for Nonalcoholic Steatohepatitis (NASH) is a Phase 1 program (small_molecule) at CORCEPT THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CORCEPT THERAPEUTICS INC
- Indication
- Nonalcoholic Steatohepatitis (NASH)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed